Marburg virus
Find information on thousands of medical conditions and prescription drugs.

Marburg fever

The Marburg virus is the causative agent of Marburg hemorrhagic fever. Both the disease and virus are related to Ebola and originate in the same part of Africa (Uganda and Eastern Congo). The zoonosis is of unknown origin, but some scientists believe it may be hosted by bats. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
Mac Ardle disease
Macroglobulinemia
Macular degeneration
Mad cow disease
Maghazaji syndrome
Mal de debarquement
Malaria
Malignant hyperthermia
Mallory-Weiss syndrome
Malouf syndrome
Mannosidosis
Marburg fever
Marfan syndrome
MASA syndrome
Mast cell disease
Mastigophobia
Mastocytosis
Mastoiditis
MAT deficiency
Maturity onset diabetes...
McArdle disease
McCune-Albright syndrome
Measles
Mediterranean fever
Megaloblastic anemia
MELAS
Meleda Disease
Melioidosis
Melkersson-Rosenthal...
Melophobia
Meniere's disease
Meningioma
Meningitis
Mental retardation
Mercury (element)
Mesothelioma
Metabolic acidosis
Metabolic disorder
Metachondromatosis
Methylmalonic acidemia
Microcephaly
Microphobia
Microphthalmia
Microscopic polyangiitis
Microsporidiosis
Microtia, meatal atresia...
Migraine
Miller-Dieker syndrome
Mitochondrial Diseases
Mitochondrial...
Mitral valve prolapse
Mobius syndrome
MODY syndrome
Moebius syndrome
Molluscum contagiosum
MOMO syndrome
Mondini Dysplasia
Mondor's disease
Monoclonal gammopathy of...
Morquio syndrome
Motor neuron disease
Motorphobia
Moyamoya disease
MPO deficiency
MR
Mucopolysaccharidosis
Mucopolysaccharidosis...
Mullerian agenesis
Multiple chemical...
Multiple endocrine...
Multiple hereditary...
Multiple myeloma
Multiple organ failure
Multiple sclerosis
Multiple system atrophy
Mumps
Muscular dystrophy
Myalgic encephalomyelitis
Myasthenia gravis
Mycetoma
Mycophobia
Mycosis fungoides
Myelitis
Myelodysplasia
Myelodysplastic syndromes
Myelofibrosis
Myeloperoxidase deficiency
Myoadenylate deaminase...
Myocarditis
Myoclonus
Myoglobinuria
Myopathy
Myopia
Myositis
Myositis ossificans
Myxedema
Myxozoa
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The disease is spread through bodily fluids, including blood, excrement, saliva, and vomit. There is no cure or vaccine for this deadly and infectious virus. Victims suffer a high fever, diarrhea, vomiting, and severe bleeding from bodily orifices and usually die within a week. Fatality rates range from 25 to 100 %.

In the spring of 2005, the virus attracted widespread press attention for an outbreak in Angola. Beginning in October 2004 and continuing into 2005, the outbreak, which is now thought to be under control, was the world's worst epidemic of any kind of hemorrhagic fever.

The Marburg virus

The viral structure is typical of filoviruses, with long threadlike particles which have a consistent diameter but vary greatly in length from an average of 800 nanometres up to 14,000 nm, with peak infectious activity at about 790 nm. Virions (viral particles) contain seven known structural proteins. While nearly identical to Ebola virus in structure, Marburg virus is antigenically distinct from Ebola virus — in other words, it triggers different antibodies in infected organisms. It was the first filovirus to be identified.

Infection details

Because many of the signs and symptoms of Marburg hemorrhagic fever are similar to those of other infectious diseases, such as malaria or typhoid, diagnosis of the disease can be difficult, especially if only a single case is involved.

The disease is characterised by the sudden onset of fever, headache, and muscle pain after an incubation period of 3-9 days. Within a week, a maculopapular rash develops, followed by vomiting, chest and abdominal pain, and diarrhea. The disease can then become increasingly damaging, causing jaundice, delirium, organ failure, and extensive hemorrhage. Patients generally die from hypovolemic shock as fluid leaks out of the blood vessels, causing blood pressure to drop.

Recovery from the disease is prolonged and can be marked by orchitis, recurrent hepatitis, transverse myelitis or uveitis, or inflammation of the spinal cord, eyes, or parotid gland. Depending upon health care and hospitalization support, the disease can have very high fatality rates, with estimates ranging from 25 % up to 100 %.

Infection is believed to be spread by close contact with body fluids of those infected, and the virus is unlikely to spread through casual contact. Patients are most contagious during the acute phase of the illness when fluids such as vomit and blood are present. Unsafe burial practices such as embracing, kissing or ritual bathing of the corpse present another infection vector.

According to a report in the New York Times, the virus moves very quickly. "On Day 3 of the infection, fewer than 200 viruses are in a drop of blood. By Day 8, there are five million."

Read more at Wikipedia.org


[List your site here Free!]


Vaccines against Marburg and Ebola viruses advance
From Science News, 7/16/05

Scientists have developed two new vaccines against the killer Ebola and Marburg viruses. In laboratory tests, the vaccines protected monkeys exposed to the viruses, which periodically infect people in Africa and cause hemorrhagic fevers marked by vomiting, diarrhea, shock, and organ shutdown. The report appears in the July Nature Medicine.

Researchers at the National Microbiology Laboratory of the Public Health Agency of Canada in Winnipeg, Manitoba, made the vaccines from a third, much less dangerous, virus that causes the livestock disease vesicular stomatitis. To make the vaccines, the researchers stripped the vesicular stomatitis virus of a particular gene and replaced it either with a gene that encodes a protein on the Marburg virus or with a gene for a protein on the Ebola virus.

The team then vaccinated four cynomolgus macaques with the Marburg vaccine and four others with the Ebola vaccine. Four weeks later, each group of animals received injections of the killer virus corresponding to its vaccine. All of the monkeys survived the normally lethal injections, says study coauthor Heinz Feldmann. Four other macaques given one or the other vaccine were exposed to the opposite virus. All died within 9 days.

Both vaccines elicited a strong antibody response, says Feldmann. The Ebola vaccine protected the monkeys against a viral subtype called Ebola Zaire. When the researchers exposed the four monkeys vaccinated against Ebola Zaire to another subtype of the virus, called Ebola Sudan, three of them died, indicating that separate vaccines may be needed against each Ebola subtype.

The vaccines might someday protect health care workers and other exposed people in sites of hemorrhagic-fever outbreaks, Feldmann says.--N S.

COPYRIGHT 2005 Science Service, Inc.
COPYRIGHT 2005 Gale Group

Return to Marburg fever
Home Contact Resources Exchange Links ebay